1. Home
  2. SNCY vs SDGR Comparison

SNCY vs SDGR Comparison

Compare SNCY & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sun Country Airlines Holdings Inc.

SNCY

Sun Country Airlines Holdings Inc.

HOLD

Current Price

$16.17

Market Cap

867.0M

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$15.14

Market Cap

925.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCY
SDGR
Founded
1982
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
867.0M
925.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
SNCY
SDGR
Price
$16.17
$15.14
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$19.50
$21.00
AVG Volume (30 Days)
666.7K
1.2M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
0.43
N/A
Revenue
$1,126,769,000.00
$255,869,000.00
Revenue This Year
$12.27
$0.76
Revenue Next Year
$7.51
$4.60
P/E Ratio
$37.60
N/A
Revenue Growth
4.74
23.29
52 Week Low
$10.14
$10.95
52 Week High
$22.29
$27.63

Technical Indicators

Market Signals
Indicator
SNCY
SDGR
Relative Strength Index (RSI) 45.66 73.89
Support Level $15.36 $11.27
Resistance Level $17.93 $19.51
Average True Range (ATR) 0.65 0.71
MACD 0.05 0.22
Stochastic Oscillator 49.16 91.87

Price Performance

Historical Comparison
SNCY
SDGR

About SNCY Sun Country Airlines Holdings Inc.

Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: